G. Ralph

3.2k total citations
28 papers, 2.2k citations indexed

About

G. Ralph is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, G. Ralph has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in G. Ralph's work include Virus-based gene therapy research (5 papers), Neurological disorders and treatments (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). G. Ralph is often cited by papers focused on Virus-based gene therapy research (5 papers), Neurological disorders and treatments (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). G. Ralph collaborates with scholars based in United Kingdom, France and Germany. G. Ralph's co-authors include Kyriacos Mitrophanous, Nicholas D. Mazarakis, Mimoun Azzouz, Susan M. Kingsman, James B. Uney, Lucy E. Walmsley, Jeremy M. Henley, Graham L. Collingridge, Peter Carmeliet and Erik Storkebaum and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

G. Ralph

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Ralph United Kingdom 19 1.3k 831 585 488 437 28 2.2k
Daniel Rochefort Canada 24 1.4k 1.1× 759 0.9× 724 1.2× 449 0.9× 419 1.0× 45 2.4k
Liang‐Fong Wong United Kingdom 26 1.2k 1.0× 763 0.9× 338 0.6× 242 0.5× 422 1.0× 37 2.3k
Stefano Amadio Italy 25 1.1k 0.9× 716 0.9× 520 0.9× 457 0.9× 308 0.7× 46 3.0k
Christopher Grunseich United States 24 2.0k 1.6× 639 0.8× 321 0.5× 430 0.9× 601 1.4× 52 2.7k
Piotr Hadaczek United States 34 1.5k 1.2× 974 1.2× 536 0.9× 202 0.4× 1.1k 2.4× 64 3.0k
Jérôme Mertens United States 24 2.9k 2.3× 1.0k 1.3× 589 1.0× 357 0.7× 298 0.7× 39 4.0k
Lluı́s Samaranch United States 28 1.0k 0.8× 768 0.9× 648 1.1× 214 0.4× 700 1.6× 49 2.2k
Hussein Daoud Canada 24 1.1k 0.9× 351 0.4× 971 1.7× 631 1.3× 627 1.4× 58 2.4k
Su-Chun Zhang United States 25 2.8k 2.2× 1.3k 1.6× 250 0.4× 440 0.9× 392 0.9× 31 3.9k
Gabriella L. Boulting United States 10 1.8k 1.5× 467 0.6× 500 0.9× 435 0.9× 201 0.5× 10 2.4k

Countries citing papers authored by G. Ralph

Since Specialization
Citations

This map shows the geographic impact of G. Ralph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ralph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ralph more than expected).

Fields of papers citing papers by G. Ralph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ralph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ralph. The network helps show where G. Ralph may publish in the future.

Co-authorship network of co-authors of G. Ralph

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ralph. A scholar is included among the top collaborators of G. Ralph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ralph. G. Ralph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Senova, Sühan, H. Lepetit, G. Ralph, et al.. (2025). Deep brain stimulation is well tolerated and effective following ProSavin® gene therapy for Parkinson's disease. Neurotherapeutics. 22(5). e00629–e00629. 1 indexed citations
2.
Badin, Romina Aron, Katie Binley, Nadja Van Camp, et al.. (2019). Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis. Molecular Therapy — Methods & Clinical Development. 14. 206–216. 19 indexed citations
3.
Palfi, Stéphane, H. Lepetit, G. Ralph, et al.. (2018). Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease. PubMed. 29(3). 148–155. 105 indexed citations
4.
Senova, Sühan, Cyril Poupon, Julien Dauguet, et al.. (2018). Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8(1). 3362–3362. 14 indexed citations
5.
Barker, G.R., Paul J. Banks, G. Ralph, et al.. (2017). Separate elements of episodic memory subserved by distinct hippocampal–prefrontal connections. Nature Neuroscience. 20(2). 242–250. 85 indexed citations
6.
Stewart, Hannah J., G. Ralph, Iain Strickland, et al.. (2016). Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease. PubMed. 27(3). 100–110. 22 indexed citations
7.
Stewart, Hannah J., Iain Strickland, Michelle Kelleher, et al.. (2010). A Stable Producer Cell Line for the Manufacture of a Lentiviral Vector for Gene Therapy of Parkinson's Disease. Human Gene Therapy. 22(3). 357–369. 27 indexed citations
8.
Jarraya, Béchir, Sabrina Boulet, G. Ralph, et al.. (2009). Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia. Science Translational Medicine. 1(2). 2ra4–2ra4. 133 indexed citations
9.
Kölbl, H., Eva‐Maria Merz, C. Anthuber, et al.. (2008). Empfehlungen der Arbeitsgemeinschaft Urogynäkologie zur Sonographie des unteren Harntraktes im Rahmen der urogynäkologischen Funktionsdiagnostik. Ultraschall in der Medizin - European Journal of Ultrasound. 17(1). 38–41. 3 indexed citations
10.
Ralph, G., et al.. (2006). Retrospective Comparison of Chemotherapy-Induced Myelotoxicity in Patients with Ovarian Cancer Under and Over 60 Years of Age. Journal of Chemotherapy. 18(6). 656–661. 3 indexed citations
11.
Ralph, G., Pippa A. Radcliffe, Liang‐Fong Wong, et al.. (2005). Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nature Medicine. 11(4). 429–433. 374 indexed citations
12.
Azzouz, Mimoun, Thanh T. Le, G. Ralph, et al.. (2004). Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. Journal of Clinical Investigation. 114(12). 1726–1731. 157 indexed citations
13.
Ashby, Michael C., Sarah A. De La Rue, G. Ralph, et al.. (2004). Removal of AMPA Receptors (AMPARs) from Synapses Is Preceded by Transient Endocytosis of Extrasynaptic AMPARs. Journal of Neuroscience. 24(22). 5172–5176. 183 indexed citations
14.
Azzouz, Mimoun, G. Ralph, Erik Storkebaum, et al.. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 429(6990). 413–417. 465 indexed citations
15.
Wong, Liang‐Fong, G. Ralph, Lucy E. Walmsley, et al.. (2004). Lentiviral-Mediated Delivery of Bcl-2 or GDNF Protects against Excitotoxicity in the Rat Hippocampus. Molecular Therapy. 11(1). 89–95. 50 indexed citations
16.
Tan, Hiang Khoon, et al.. (2003). Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Molecular and Cellular Neuroscience. 22(1). 98–106. 72 indexed citations
17.
Ralph, G., Ali Bienemann, Jingtao Ma, et al.. (2001). Disruption of the GluR2-NSF Interaction Protects Primary Hippocampal Neurons from Ischemic Stress. Molecular and Cellular Neuroscience. 17(4). 662–670. 16 indexed citations
18.
Tamussino, Karl, E. Hanzal, D. Kölle, G. Ralph, & P. Riss. (2001). The Austrian Tension-Free Vaginal Tape Registry. International Urogynecology Journal. 12(0). S28–S30. 48 indexed citations
19.
20.
Noël, Jacques, G. Ralph, Lisa Pickard, et al.. (1999). Surface Expression of AMPA Receptors in Hippocampal Neurons Is Regulated by an NSF-Dependent Mechanism. Neuron. 23(2). 365–376. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Rochefort Breakdown of academic impact, for papers by Liang‐Fong Wong Breakdown of academic impact, for papers by Stefano Amadio Breakdown of academic impact, for papers by Christopher Grunseich Breakdown of academic impact, for papers by Piotr Hadaczek Breakdown of academic impact, for papers by Jérôme Mertens Breakdown of academic impact, for papers by Lluı́s Samaranch Breakdown of academic impact, for papers by Hussein Daoud Breakdown of academic impact, for papers by Su-Chun Zhang Breakdown of academic impact, for papers by Gabriella L. Boulting
Rankless by CCL
2026